Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03411902 · ClinicalTrials.gov registry record · Phase 4
Weight Loss With Risedronate for Bone Health
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT03411902 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 24 participants.
The verdict
NCT03411902, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a pilot project to determine the feasibility of recruiting, enrolling, treating, and following 24 older sleeve gastrectomy patients into a randomized controlled trial (RCT) examining the efficacy of bisphosphonate use versus placebo in the prevention of surgical weight loss associated loss of bone mass and quality.
Interventions
- OTHER Placebo
- DRUG Risedronate Sodium 150 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2020-07-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03411902
The ClinicalTrials.gov registry entry for NCT03411902 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03411902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03411902 about?
NCT03411902 is a clinical study titled "Weight Loss With Risedronate for Bone Health". This is a pilot project to determine the feasibility of recruiting, enrolling, treating, and following 24 older sleeve gastrectomy patients into a randomized controlled trial (RCT) examining the efficacy of bisphosphonate use versus placebo in the prevention of surgical weight loss associated loss o...
What is the current status of trial NCT03411902?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2018-06-15. Estimated completion is 2020-07-22.
What interventions are being tested in trial NCT03411902?
The interventions under investigation include: Placebo (OTHER), Risedronate Sodium 150 MG (DRUG).
Who is sponsoring clinical trial NCT03411902?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.